319 related articles for article (PubMed ID: 19508382)
1. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.
Marvie P; Lisbonne M; L'helgoualc'h A; Rauch M; Turlin B; Preisser L; Bourd-Boittin K; Théret N; Gascan H; Piquet-Pellorce C; Samson M
J Cell Mol Med; 2010 Jun; 14(6B):1726-39. PubMed ID: 19508382
[TBL] [Abstract][Full Text] [Related]
2. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
3. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
Tan Z; Liu Q; Jiang R; Lv L; Shoto SS; Maillet I; Quesniaux V; Tang J; Zhang W; Sun B; Ryffel B
Cell Mol Immunol; 2018 Apr; 15(4):388-398. PubMed ID: 28194023
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic expressions of IL-22 and hepatic stellate cells senescence in mice infected with Schistosoma japonicum].
Li L; Sun Y; Wang HW; Huang Y; Huang JQ; Ning Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Apr; 26(2):169-74. PubMed ID: 25051830
[TBL] [Abstract][Full Text] [Related]
6. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
8. Th2 Cell Activation in Chronic Liver Disease Is Driven by Local IL33 and Contributes to IL13-Dependent Fibrogenesis.
Reißing J; Berres M; Strnad P; Wree A; Inzaugarat ME; Trautwein C; Bruns T; Zimmermann HW
Cell Mol Gastroenterol Hepatol; 2024; 17(4):517-538. PubMed ID: 38158122
[TBL] [Abstract][Full Text] [Related]
9. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 participates in the progression from liver injury to fibrosis.
Gieling RG; Wallace K; Han YP
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1324-31. PubMed ID: 19342509
[TBL] [Abstract][Full Text] [Related]
11. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
13. IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells.
Beringer A; Miossec P
Clin Exp Immunol; 2019 Oct; 198(1):111-120. PubMed ID: 31102558
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
15. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
Xiang DM; Sun W; Ning BF; Zhou TF; Li XF; Zhong W; Cheng Z; Xia MY; Wang X; Deng X; Wang W; Li HY; Cui XL; Li SC; Wu B; Xie WF; Wang HY; Ding J
Gut; 2018 Sep; 67(9):1704-1715. PubMed ID: 28754776
[TBL] [Abstract][Full Text] [Related]
16. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
17. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
[TBL] [Abstract][Full Text] [Related]
18. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells.
Ceni E; Mello T; Polvani S; Vasseur-Cognet M; Tarocchi M; Tempesti S; Cavalieri D; Beltrame L; Marroncini G; Pinzani M; Milani S; Galli A
J Hepatol; 2017 Apr; 66(4):754-764. PubMed ID: 27866920
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
Jiang Y; Chen P; Hu K; Dai G; Li J; Zheng D; Yuan H; He L; Xie P; Tu M; Peng S; Qu C; Lin W; Chung RT; Hong J
J Cell Mol Med; 2021 Feb; 25(3):1568-1582. PubMed ID: 33410581
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
